People · Operator
Named in public records as an officer, director or promoter · active 2014–2022 · Pharma, Other Health Care, Other, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pyxis Oncology, Inc. | — | Pharma | Series D+ | $194.5M | $5.0B | 2019 |
| Endotronix Inc | — | Other Health Care | Series C | $116.1M | $1.6B | 2018 |
| ClostraBio, Inc. | — | Other | Series A | $9.9M | $77.7M | 2022 |
| AltaThera Pharmaceuticals, LLC | — | Pharmaceuticals | Seed | $7.6M | $58.3M | 2014 |
John Flavin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Flavin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Steinberg | 1 | 14 |
| PAUL LAVIOLETTE | 1 | 12 |
| Marc Goldberg | 1 | 9 |
| Fouad Azzam | 1 | 8 |
| Christopher O'Donnell | 1 | 8 |
| Christoph Westphal | 1 | 8 |
| Geeta Vemuri | 1 | 7 |
| Robert Crane | 1 | 7 |
| Lucio Iannone | 1 | 6 |
| ROBERT ZIESERL | 1 | 5 |
| Gerry Brunk | 1 | 5 |
| Rick White | 1 | 4 |
| Jak Knowles | 1 | 4 |
| Kent Elmer | 1 | 2 |
| Jeffrey Hubbell | 1 | 2 |
| Christian Schetter | 1 | 2 |
| James Hummer | 1 | 2 |
| Anthony A. Nunez | 1 | 1 |
| Leslie A. Saxon | 1 | 1 |
| Reed Prior | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.